bioTRAK® Biologics Manufacturing Market Intelligence

Request a Custom Report

Enable More Informed Biologics Manufacturing Decisions with the Industry’s Most Comprehensive Market Intelligence

Identify emerging capacity constraints, hidden investment opportunities, and outsourcing strategies with in-depth biologics manufacturing data and forward-looking strategic forecasts.

Bar graph showing in-house demand vs. outsourced demand.

Chart showing capacity demand.

bioTRAK® Market Intelligence

bioTRAK® Market Intelligence provides the most detailed dataset available on global biologics manufacturing capacity and demand and helps organizations make faster, data-driven, lower-risk decisions.

  • Detailed global bioreactor capacity segmented by region, company type, and facility 
  • Near-term and long-term supply and demand projections 
  • Analysis of current and emerging technologies impacting the biopharma landscape.

Available Reports

Select from flexible reporting options tailored to your needs, whether a one-time report or a complete suite covering mammalian and microbial supply and demand:

Life-science-bio-defense-research-R

Mammalian Supply Analysis (Most Purchased)

Molecule-R

Mammalian Demand Analysis

Test-tube-R

Microbial Supply Analysis

Beaker-2-R

Microbial Demand Analysis

Each report delivers deep, decision-grade intelligence used by executives, investors, and strategy teams across the biopharmaceutical ecosystem, and can serve as a foundation for customized market analyses tailored to your organization’s specific information needs.

Key Questions We Help Clients Answer

  • Is the trend towards outsourced biomanufacturing continuing, or do product companies capture most new capacity?
  • Is growth in mammalian manufacturing primarily driven by monoclonal antibody therapeutics?
  • Could pipeline products lead to future microbial capacity constraints despite limited current expansion?
  • How are geographic shifts reshaping global biologics supply chains?

Bar graph showing reactors.

Why bioTRAK®

Empower your decision-making in biologics manufacturing.

Data-1

20+ years of highly curated biomanufacturing data

Beakers-2-R

Coverage of 170+ companies and 300+ manufacturing sites worldwide involved in the development and production of more than 2,000 recombinant biopharmaceuticals

tablet-graph-R

Independent, data-driven analysis

Team-process-R

Trusted by industry leaders making high-value decisions